These findings corroborate the differential concentrationsof TNC+ EVs in the blood circulation of glioblastoma patients.Taken together, TNC emerged as the most attractive antigen hereininvestigated, showing potential as a biomarker for glioblastoma. The gene discussed is TNC; the disease is glioblastoma.